SHARONE PERLMAN: Open Payments
NPI 1548631419 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,920 in 122 payments from 26 companies in 2025. Trend: 2023 $2,476 · 2024 $2,142 · 2025 $2,920
Food & beverage: $2,920
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $380 |
| ABBVIE INC. | 17 | $363 |
| Corcept Therapeutics | 10 | $297 |
| Novartis Pharmaceuticals Corporation | 19 | $288 |
| Galvanize Therapeutics, Inc | 1 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $212 |
| Novo Nordisk Inc | 11 | $168 |
| Lilly USA, LLC | 11 | $155 |
| INTUITIVE SURGICAL, INC. | 1 | $100 |
| Exact Sciences Corporation | 3 | $98 |
Products named: VRAYLAR, Korlym, LEQVIO, ALIYA SYSTEM, JARDIANCE, FARXIGA, Wegovy, BREZTRI.
Industry payments across CA — which companies pay providers there.
